Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01420575 · ClinicalTrials.gov registry record · NA
Decision Aid to Facilitate Shared Decision Making During Treatment in Schizophrenia
A NA study, sponsored by VA Nebraska Western Iowa Health Care System.
- Terminated
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT01420575: Clinical Trial NA study, sponsored by VA Nebraska Western Iowa Health Care System.
NCT01420575 is a NA study that was terminated before completion, run by VA Nebraska Western Iowa Health Care System. The registered enrollment target is 8 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01420575, a NA study, was terminated before completion, sponsored by VA Nebraska Western Iowa Health Care System.
- TERMINATED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
We hypothesize that the use of a visual decision aid tool to educate patients regarding potential harm with respect to weight gain with olanzapine versus perphenazine can lead to better shared decision making by patients, increase rates of antipsychotic switches and promote weight loss in overweight patients with schizophrenia/schizoaffective disorder. Our specific aims are the following: 1. To investigate the effects of a visual decision aid, versus care as usual, on patients' perceived difficulties in medical decision making regarding switching antipsychotics in overweight veterans with schizophrenia or schizoaffective disorder. 2. To investigate the effects of a visual decision aid and a shared decision making model on rate of medication switches (from olanzapine to perphenazine) in overweight veterans with schizophrenia or schizoaffective disorder. 3. To investigate the effects of a visual decision making aid and shared decision making model on BMI in overweight veterans who switch from olanzapine to perphenazine therapy.
Interventions
- BEHAVIORAL Usual Care
- BEHAVIORAL Visual Decision Aid and Shared Decision Making Model
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2010-10 |
| Est. Completion | 2012-08 |
| Phase | NA |
Why NCT01420575 stopped before completion
NCT01420575 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Usual Care is the first listed.
NCT01420575 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01420575 about?
NCT01420575 is a clinical study titled "Decision Aid to Facilitate Shared Decision Making During Treatment in Schizophrenia". We hypothesize that the use of a visual decision aid tool to educate patients regarding potential harm with respect to weight gain with olanzapine versus perphenazine can lead to better shared decision making by patients, increase rates of antipsychotic switches and promote weight loss in overweight...
What is the current status of trial NCT01420575?
This trial is currently terminated. It is a NA study. The enrollment target is 8 participants. The study started on 2010-10. Estimated completion is 2012-08.
What interventions are being tested in trial NCT01420575?
The interventions under investigation include: Usual Care (BEHAVIORAL), Visual Decision Aid and Shared Decision Making Model (BEHAVIORAL).
Who is sponsoring clinical trial NCT01420575?
This trial is sponsored by VA Nebraska Western Iowa Health Care System, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01420575's enrollment target sits among peer trials
8 1976th of 2000 higher than 19 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia